Description
Besponsa 1mg Injection is a CD22-directed antibody-drug conjugate (ADC) used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Additional information
| Brand | Besponsa |
|---|---|
| Generic name | Inotuzumab Ozogamacin injection |
| Form | Parenteral |
| Strength | 1mg |
| Manufacturer | Pfizer |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.